Pharmalot... Pharmalittle... Good Morning

Rise and shine. Another busy day is on the way. And while there are cloudy skies hovering over the Pharmalot corporate campus this morning, our spirits remain sunny. You know why, yes? As the Morning Mayor would say: Every brand new day should be unwrapped like a precious gift. We have not repeated this for awhile, so we thought it is time to do so. Meanwhile, whlie you tug on the ribbon, have a cup of stimulation on us. And, of course, here are your tidbits. Have a smashing day and thanks to those who have reached out with interesting information... Bristol-Myers Scraps Forecast As New Bloodthinner Struggles (Reuters) Lonza Scraps Biosimilar Joint Venture With Teva (Reuters) Indian Court Questions FDA Notice Delay To J&J (Indian Express) FDA Accepts Review Of Long-Delayed Merck Blood Clot Drug (Yahoo Finance) Roche First-Half Profit Climbs 10 Percent On Cancer Meds (Bloomberg News) Biogen Offices Remove Cubicles To Revamp Culture (Boston Globe) Sarepta Seeks Early FDA Approval For Muscular Dystrophy Drug (TheStreet) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs